Missing a sales target is one thing. NEU royalty receipts are all profit and largely still intact with an Acadia modest sales target miss.
Acadia guidance for net sales in 2024 is still intact. A first sales milestone payment of US$50 million to Neuren is expected to be earned for 2024 on Daybue sales reaching US$250M.
Things could be much worse.
Kens
- Forums
- ASX - By Stock
- Acadia
Missing a sales target is one thing. NEU royalty receipts are...
- There are more pages in this discussion • 122 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$18.84 |
Change
-0.180(0.95%) |
Mkt cap ! $2.404B |
Open | High | Low | Value | Volume |
$18.96 | $19.06 | $18.72 | $3.495M | 185.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
14 | 1308 | $18.84 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.85 | 7 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2 | 18.850 |
13 | 1502 | 18.840 |
8 | 552 | 18.830 |
5 | 453 | 18.820 |
9 | 995 | 18.810 |
Price($) | Vol. | No. |
---|---|---|
18.860 | 69 | 6 |
18.870 | 388 | 9 |
18.880 | 469 | 10 |
18.890 | 951 | 16 |
18.900 | 1120 | 8 |
Last trade - 14.28pm 12/06/2024 (20 minute delay) ? |
|
|||||
Last
$18.84 |
  |
Change
-0.180 ( 0.13 %) |
|||
Open | High | Low | Volume | ||
$18.95 | $19.02 | $18.72 | 69710 | ||
Last updated 14.46pm 12/06/2024 ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
SPONSORED BY The Market Online